MedTrace Logo

Microbial Markers for AGI

NCT04957888 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 584

Last updated 2021-07-12

No results posted yet for this study

Summary

AGI is very common in ICU and sometimes will trigger the development of gut derived sepsis. Thus, to find out the biomarker in early stage is very important to improve the overall prognosis of critically ill patients. In this project we try to find out the microbial biomarker of AGI through multi-omic technology.

Conditions

  • Acute Gastrointestinal Injury

Interventions

OTHER

none intervention

none intervention.

Sponsors & Collaborators

  • Shanghai Jiao Tong University School of Medicine

    collaborator OTHER

  • Peking University Third Hospital

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-07-01
Primary Completion
2021-06-01
Completion
2021-07-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04957888 on ClinicalTrials.gov